The Idaho Court of Appeals has upheld the conviction of Chance Steve Richard Worosz for possession of a controlled substance. This ruling, issued on July 31, 2026, clarifies the legal protections provided under the Syringe and Needle Exchange Act (SNEA) and its limitations regarding individual immunity from drug possession charges.
The case began when Worosz was found sleeping in a park after hours. An officer arrested him for trespassing and subsequently searched him. During the search, the officer discovered over fifty unused syringes and a used syringe containing a white residue that tested positive for methamphetamine. Worosz claimed he was participating in a needle exchange program and argued that the SNEA protected him from prosecution. However, the State charged him with possession of a controlled substance and drug paraphernalia.
Worosz contested the legality of his arrest, asserting that his actions were protected under the SNEA, which was enacted in 2019 to reduce the transmission of diseases among individuals who inject drugs. He argued that the law conflicted with existing drug possession statutes, placing individuals in a precarious position. The district court denied his motion, stating that the SNEA does not grant immunity to individuals like Worosz, only to entities operating exchange programs.
Worosz’s appeal centered on the claim that the district court abused its discretion by denying his motion to dismiss. He contended that the SNEA should protect individuals from prosecution for possessing syringes and drug residue. However, the court found that the SNEA’s protections were designed for entities, not individuals, and did not alter the criminality of drug possession.
The Idaho Court of Appeals, led by Judge Lorello, affirmed the district court's ruling. The court stated, “Worosz has failed to show the district court erred in denying his motion to dismiss.” The judges noted that the SNEA was intended to facilitate safe syringe exchanges but did not provide individuals with immunity from drug possession laws.
This ruling has significant implications for individuals involved in needle exchange programs. It clarifies that while the SNEA aims to reduce health risks associated with drug use, it does not shield individuals from criminal charges related to drug possession. This decision may affect how law enforcement interacts with individuals using needle exchange services in the future.
The court’s ruling also emphasizes the importance of understanding the limitations of the SNEA. Although the law was designed to promote public health by allowing syringe exchanges, it does not protect individuals who possess controlled substances or drug paraphernalia. This distinction is critical for individuals who may rely on these programs for harm reduction.
Looking ahead, the ruling may prompt discussions about the need for legislative changes to better protect individuals participating in harm reduction programs. Advocates for drug policy reform may argue that the law should be amended to provide clearer protections for individuals using needle exchange services.
As for Worosz, the court’s decision affirms his conviction, leaving him with limited options for appeal. The case highlights ongoing challenges in the intersection of drug laws and public health initiatives, illustrating the complexities faced by individuals trying to navigate these systems.
Details were not available in the court filing regarding any potential further legal actions Worosz may pursue. However, the ruling sets a precedent that could influence future cases involving the SNEA and drug possession laws in Idaho.